BofA raises Lockheed Martin stock price target on strong outlook

Lockheed Martin reported Q3 2026 EPS of $7.97 versus $7.52 consensus and revenue of $20.7 billion versus $20.48 billion, with sales up 11% year over year, and raised its full-year outlook. BofA lifted its price target to $620 from $600 but maintained a Neutral rating, citing growth in Missiles and Fire Control and accelerating F-35 sales while flagging Aeronautics margin pressure and potential 2027 cash headwinds. The stock gained 6.44% on the results day while the S&P 500 fell 1.4%.

Analysis

LMT: Earnings quality matters more than the beat

The immediate risk is chasing a sharp, company-specific move while the market is signaling caution: analyst target increases do not establish that the shares remain attractive at the post-results price. Treat the reaction as evidence of improving execution, not yet proof of durable free-cash-flow upside. BofA’s Neutral stance alongside its higher target is a useful reminder that better operating momentum can coexist with limited near-term risk/reward.

Over the next 1–3 months, monitor whether raised expectations convert into delivery cadence, segment margin progress, and cash generation—not just reported EPS. Classified-program growth is difficult for investors to independently underwrite; any slippage or weaker cash conversion could quickly erode confidence. Persistent Aeronautics margin pressure is the clearest counterweight, with the cited 2027 cash headwind a longer-dated risk to valuation if it becomes more severe or arrives earlier than expected.

At 6–18 months, a sustained production ramp could support LMT and related defense suppliers, but it may also redirect investor capital toward whichever prime demonstrates better cash conversion and execution. Northrop Grumman, RTX, and General Dynamics are relevant relative-value comparators, not automatic beneficiaries or shorts. The contrarian risk is that investors extrapolate one strong quarter into a smooth growth trajectory despite opaque program economics and execution-sensitive cash flows. The thesis weakens if guidance or delivery expectations are cut, Aeronautics margins deteriorate further, or cash conversion fails to track earnings.

Key Decisions for Investors

• Do not chase the post-results outperformance. For new exposure, wait for a pullback or for the next update to confirm that delivery growth is translating into cash; no price target is justified by the supplied information.
• For existing positions, retain exposure only while guidance and delivery cadence hold. Reassess on any downward outlook revision, weaker-than-expected free-cash-flow conversion, or further Aeronautics margin deterioration; these would falsify the improving-execution thesis.
• Track LMT against Northrop Grumman, RTX, and General Dynamics on subsequent guidance, margins, and cash conversion before considering a relative-value trade. Missing inputs include current valuation, segment-level cash flow, and peer operating trends; without them, a pair trade or options position is not well supported.